Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Biomarin Pharmaceutical Inc (BMRN)  
$88.63 1.44 (1.6%) as of 4:30 Fri 4/19


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 188,370,000
Market Cap: 16.70(B)
Last Volume: 1,778,607 Avg Vol: 1,398,026
52 Week Range: $76.22 - $99
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  811
Guru Rank Value     : 0.9
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   BioMarin Pharmaceutical is a biotechnology company that develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Co.'s commercial products are Aldurazyme (laronidase) for Mucopolysaccharidosis I; Brineura (cerliponase alfa) for the treatment of late infantile neuronal ceroid lipofuscinosis type 2; Kuvan (sapropterin dihydrochloride) for the treatment of phenylketonuria; Naglazyme (galsulfase) the treatment of Mucopolysaccharidosis VI ; Palynziq (pegvaliase-pqpz) for adult patients with phenylketonuria; and Vimizim (elosulfase alpha) for the treatment of Mucopolysaccharidosis IV Type A.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 3,625
Total Buy Value $0 $0 $0 $314,469
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 159,588 261,929 319,053 656,089
Total Sell Value $13,270,852 $22,448,451 $27,661,182 $61,420,002
Total People Sold 5 6 7 7
Total Sell Transactions 10 20 27 56
End Date 2024-03-21 2023-12-19 2023-06-20 2022-06-20

   
Records found: 1303
  Page 48 of 53  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2007-09-19 4 OE $6.46 $64,600 D/D 10,000 16,695     -
   Baffi Robert SVP, Technical Operations   •       –      –    2007-09-14 4 S $22.34 $1,512,772 D/D (67,293) 55,831     -
   Baffi Robert SVP, Technical Operations   •       –      –    2007-09-14 4 OE $6.13 $551,700 D/D 90,000 123,124     -
   Baffi Robert SVP, Technical Operations   •       –      –    2007-09-14 4 S $22.61 $514,015 D/D (22,707) 33,124     -
   Aselage Steve SVP, Global Commercial Dev.   •       –      –    2007-09-14 4 S $22.40 $224,000 D/D (10,000) 4,895     -
   Aselage Steve SVP, Global Commercial Dev.   •       –      –    2007-09-14 4 OE $7.16 $71,600 D/D 10,000 14,895     -
   Cooper Jeffrey H SVP, Chief Financial Officer   •       –      –    2007-09-06 4 AS $22.50 $304,560 D/D (13,536) 0     -
   Cooper Jeffrey H SVP, Chief Financial Officer   •       –      –    2007-09-06 4 OE $8.10 $109,642 D/D 13,536 13,536     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2007-08-17 4 S $21.00 $210,000 D/D (10,000) 6,695     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2007-08-17 4 OE $6.46 $64,600 D/D 10,000 16,695     -
   Cooper Jeffrey H SVP, Chief Financial Officer   •       –      –    2007-08-17 4 S $20.12 $405,705 D/D (20,000) 0     -
   Cooper Jeffrey H SVP, Chief Financial Officer   •       –      –    2007-08-17 4 OE $5.15 $132,996 D/D 20,000 20,000     -
   Davis George Eric VP, General Counsel   •       –      –    2007-08-15 4 S $20.26 $81,040 D/D (4,000) 2,607     -
   Davis George Eric VP, General Counsel   •       –      –    2007-08-15 4 OE $6.13 $24,520 D/D 4,000 6,607     -
   Wood Mark VP, Human Resources   •       –      –    2007-08-10 4 S $21.08 $55,504 D/D (2,633) 0     -
   Wood Mark VP, Human Resources   •       –      –    2007-08-10 4 OE $6.13 $22,278 D/D 2,633 2,633     -
   Lewis Alan Director   –       •      –    2007-08-10 4 S $20.00 $401,633 D/D (20,000) 10,000     -
   Lewis Alan Director   –       •      –    2007-08-10 4 OE $7.72 $231,600 D/D 30,000 30,000     -
   Aselage Steve SVP, Global Commercial Dev   •       –      –    2007-08-10 4 S $20.21 $405,389 D/D (20,000) 4,895     -
   Aselage Steve SVP, Global Commercial Dev   •       –      –    2007-08-10 4 OE $7.16 $143,200 D/D 20,000 24,895     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2007-08-10 4 S $20.20 $724,917 D/D (35,886) 6,695     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2007-08-10 4 OE $6.46 $231,824 D/D 35,886 42,581     -
   Cooper Jeffrey H SVP, Chief Financial Officer   •       –      –    2007-08-08 4 AS $21.00 $262,500 D/D (12,500) 0     -
   Cooper Jeffrey H SVP, Chief Financial Officer   •       –      –    2007-08-08 4 OE $8.10 $101,250 D/D 12,500 12,500     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2007-08-03 4 AS $18.00 $36,053 D/D (2,000) 6,695     -
  1303 Records found
  Previous  40  41  42  43  44  45  46  47  48  49  Next   
  Page 48 of 53
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us